Literature DB >> 17362778

Immediate recovery of renal function after orthotopic liver transplantation in a patient with hepatorenal syndrome requiring hemodialysis for more than 8 months.

C Storm1, W M Bernhardt, E Schaeffner, R Neuhaus, A Pascher, P Neuhaus, D Hasper, U Frei, A Kahl.   

Abstract

Severe liver dysfunction may lead to impairment of renal function without an underlying renal pathology. This phenomenon is called hepatorenal syndrome (HRS), which is associated with a poor prognosis showing a median survival of less than 2 months if renal replacement therapy is necessary. Liver transplantation is the best therapeutic option to regain renal function, but because of poor survival, these patients often die before transplantation. Herein we report a 37-year-old patient with ethyl-toxic liver cirrhosis who underwent hemodialysis due to HRS type I for more than 8 months. After living donor liver transplantation, diuresis immediately resumed, renal function soon recovered, and intermittent hemodialysis was stopped at 18 days after transplantation. Renal function was stable with a serum creatinine <2 mg/dL during the last 5 years posttransplantation. As far as we know, only a few cases of an anuric patient suffering from HRS have been reported with a survival beyond 8 months and full recovery of renal function after liver transplantation. This underlined that renal replacement therapy in HRS should be considered as a possible bridging method to liver transplantation even for longer periods.

Entities:  

Mesh:

Year:  2007        PMID: 17362778     DOI: 10.1016/j.transproceed.2006.12.006

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  2 in total

1.  Dialysis-dependent acute kidney injury in children with end-stage liver disease: prevalence, dialysis modalities and outcome.

Authors:  Martin Kreuzer; Dagmar Gähler; Annette C Rakenius; Jenny Prüfe; Thomas Jack; Eva-Doreen Pfister; Lars Pape
Journal:  Pediatr Nephrol       Date:  2015-08-01       Impact factor: 3.714

2.  Management and outcome in hepatorenal syndrome: need for renal replacement therapy in non-transplanted patients.

Authors:  Achuthan Sourianarayanane; Rupesh Raina; Gaurav Garg; Arthur J McCullough; Robert S O'Shea
Journal:  Int Urol Nephrol       Date:  2013-08-10       Impact factor: 2.370

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.